Annual Total Liabilities
$244.07 M
+$22.91 M+10.36%
31 December 2023
Summary:
Pharming Group NV annual total liabilities is currently $244.07 million, with the most recent change of +$22.91 million (+10.36%) on 31 December 2023. During the last 3 years, it has risen by +$9.05 million (+3.85%). PHAR annual total liabilities is now at all-time high.PHAR Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$199.72 M
+$4.73 M+2.43%
30 September 2024
Summary:
Pharming Group NV quarterly total liabilities is currently $199.72 million, with the most recent change of +$4.73 million (+2.43%) on 30 September 2024. Over the past year, it has dropped by -$26.80 million (-11.83%). PHAR quarterly total liabilities is now -18.17% below its all-time high of $244.07 million, reached on 31 December 2023.PHAR Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAR Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.4% | -11.8% |
| 3 y3 years | +3.9% | -3.7% |
| 5 y5 years | +39.7% | +40.0% |
PHAR Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +19.4% | -18.2% | +9.7% |
| 5 y | 5 years | at high | +76.2% | -18.2% | +44.2% |
| alltime | all time | at high | +3423.8% | -18.2% | +699.7% |
Pharming Group NV Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $199.72 M(+2.4%) |
| June 2024 | - | $194.99 M(-17.3%) |
| Mar 2024 | - | $235.72 M(-3.4%) |
| Dec 2023 | $244.07 M(+10.4%) | $244.07 M(+7.7%) |
| Sept 2023 | - | $226.53 M(-1.3%) |
| June 2023 | - | $229.43 M(+2.6%) |
| Mar 2023 | - | $223.65 M(+1.1%) |
| Dec 2022 | $221.16 M(+8.2%) | $221.16 M(+21.5%) |
| Sept 2022 | - | $182.07 M(-6.3%) |
| June 2022 | - | $194.23 M(-2.3%) |
| Mar 2022 | - | $198.78 M(-2.8%) |
| Dec 2021 | $204.40 M(-13.0%) | $204.40 M(-1.4%) |
| Sept 2021 | - | $207.37 M(-3.0%) |
| June 2021 | - | $213.87 M(-3.9%) |
| Mar 2021 | - | $222.54 M(-5.3%) |
| Dec 2020 | $235.02 M(+69.7%) | $235.02 M(+9.3%) |
| Sept 2020 | - | $214.96 M(+0.8%) |
| June 2020 | - | $213.17 M(+2.6%) |
| Mar 2020 | - | $207.70 M(+49.9%) |
| Dec 2019 | $138.53 M(-20.7%) | $138.53 M(-2.9%) |
| Sept 2019 | - | $142.60 M(-2.2%) |
| June 2019 | - | $145.88 M(-0.5%) |
| Mar 2019 | - | $146.54 M(-16.1%) |
| Dec 2018 | $174.71 M(-3.0%) | $174.71 M(+4.0%) |
| Sept 2018 | - | $167.96 M(+3.2%) |
| June 2018 | - | $162.68 M(-5.1%) |
| Mar 2018 | - | $171.46 M(-4.8%) |
| Dec 2017 | $180.05 M(+72.4%) | $180.05 M(+14.7%) |
| Sept 2017 | - | $157.04 M(+14.2%) |
| June 2017 | - | $137.50 M(+25.5%) |
| Mar 2017 | - | $109.53 M(+4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $104.45 M(+182.3%) | $104.45 M(+174.8%) |
| Sept 2016 | - | $38.00 M(-3.8%) |
| June 2016 | - | $39.50 M(+0.3%) |
| Mar 2016 | - | $39.37 M(+6.4%) |
| Dec 2015 | $37.00 M(+17.6%) | $37.00 M(-10.1%) |
| Sept 2015 | - | $41.16 M(+64.8%) |
| June 2015 | - | $24.97 M(-5.8%) |
| Mar 2015 | - | $26.51 M(-15.7%) |
| Dec 2014 | $31.46 M(-13.7%) | $31.46 M(-0.3%) |
| Sept 2014 | - | $31.57 M(-19.7%) |
| June 2014 | - | $39.30 M(+9.5%) |
| Mar 2014 | - | $35.88 M(-1.6%) |
| Dec 2013 | $36.45 M(+12.5%) | $36.45 M(+6.7%) |
| Sept 2013 | - | $34.15 M(-10.5%) |
| June 2013 | - | $38.15 M(-15.9%) |
| Mar 2013 | - | $45.36 M(+40.0%) |
| Dec 2012 | $32.40 M(-3.4%) | $32.40 M(-5.7%) |
| Sept 2012 | - | $34.36 M(-17.6%) |
| Mar 2012 | - | $41.69 M(+24.3%) |
| Dec 2011 | $33.55 M(-7.2%) | $33.55 M(-3.3%) |
| Sept 2011 | - | $34.69 M(-6.8%) |
| June 2011 | - | $37.21 M(+7.2%) |
| Mar 2011 | - | $34.72 M(-4.0%) |
| Dec 2010 | $36.16 M(-40.7%) | $36.16 M(-27.1%) |
| Sept 2010 | - | $49.63 M(-32.9%) |
| June 2010 | - | $74.01 M(-0.8%) |
| Mar 2010 | - | $74.57 M(+22.3%) |
| Dec 2009 | $60.99 M(-35.8%) | $60.99 M |
| Dec 2008 | $94.95 M(-21.9%) | - |
| Dec 2007 | $121.64 M(+215.2%) | - |
| Dec 2006 | $38.59 M(+457.1%) | - |
| Dec 2005 | $6.93 M | - |
FAQ
- What is Pharming Group NV annual total liabilities?
- What is the all time high annual total liabilities for Pharming Group NV?
- What is Pharming Group NV annual total liabilities year-on-year change?
- What is Pharming Group NV quarterly total liabilities?
- What is the all time high quarterly total liabilities for Pharming Group NV?
- What is Pharming Group NV quarterly total liabilities year-on-year change?
What is Pharming Group NV annual total liabilities?
The current annual total liabilities of PHAR is $244.07 M
What is the all time high annual total liabilities for Pharming Group NV?
Pharming Group NV all-time high annual total liabilities is $244.07 M
What is Pharming Group NV annual total liabilities year-on-year change?
Over the past year, PHAR annual total liabilities has changed by +$22.91 M (+10.36%)
What is Pharming Group NV quarterly total liabilities?
The current quarterly total liabilities of PHAR is $199.72 M
What is the all time high quarterly total liabilities for Pharming Group NV?
Pharming Group NV all-time high quarterly total liabilities is $244.07 M
What is Pharming Group NV quarterly total liabilities year-on-year change?
Over the past year, PHAR quarterly total liabilities has changed by -$26.80 M (-11.83%)